These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2779868)

  • 41. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century.
    Kweder SL
    Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):605-9. PubMed ID: 18704917
    [No Abstract]   [Full Text] [Related]  

  • 42. FDA implements plan to shorten AIDS research.
    Natl Dent Assoc J; 1988; 44(2):18. PubMed ID: 3270782
    [No Abstract]   [Full Text] [Related]  

  • 43. The clinical application of recombinant erythropoietin in the HIV-infected patient.
    Glaspy JA; Chap L
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):945-59. PubMed ID: 7852217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant human erythropoietin for long-term treatment of anemia in paroxysmal nocturnal hemoglobinuria.
    Balleari E; Gatti AM; Mareni C; Massa G; Marmont AM; Ghio R
    Haematologica; 1996; 81(2):143-7. PubMed ID: 8641643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DOXIL approved by FDA.
    AIDS Patient Care; 1995 Dec; 9(6):306. PubMed ID: 11361446
    [No Abstract]   [Full Text] [Related]  

  • 46. FDA likely to further restrict erythropoietin use for cancer patients.
    Fox JL
    Nat Biotechnol; 2007 Jun; 25(6):607-8. PubMed ID: 17557084
    [No Abstract]   [Full Text] [Related]  

  • 47. FDA approves human growth hormone for wasting syndrome.
    AIDS Patient Care STDS; 1996 Dec; 10(6):379-80. PubMed ID: 11361571
    [No Abstract]   [Full Text] [Related]  

  • 48. Growth hormone cut down at the pass.
    Gilden D
    GMHC Treat Issues; 1996 Mar; 10(3):6. PubMed ID: 11363391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amid health concerns, FDA reviews safety of several heavily used anemia drugs.
    Tuma RS
    J Natl Cancer Inst; 2007 May; 99(10):746-7, 753. PubMed ID: 17505066
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of anemia in premature infants using recombinant human erythropoietin].
    de Haas V; Raaijmaakers BC; Semmekrot BA; Kollée LA
    Ned Tijdschr Geneeskd; 1995 Apr; 139(15):773-6. PubMed ID: 7723878
    [No Abstract]   [Full Text] [Related]  

  • 51. [Human recombinant erythropoietin in the treatment of the anemia of multiple myeloma].
    Valladares Ayerbes MJ; Valenzuela Claros JC; Reina Zoilo JJ; Ruiz Borrego M; Moreno Nogueira JA
    An Med Interna; 1997 Nov; 14(11):593-4. PubMed ID: 9445590
    [No Abstract]   [Full Text] [Related]  

  • 52. Use of recombinant human erythropoietin to treat the anemia of myelodysplastic syndromes.
    Greenberg PL
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):22-4. PubMed ID: 8153674
    [No Abstract]   [Full Text] [Related]  

  • 53. FDA 'remains committed' to quick approval of AIDS drugs.
    Am Pharm; 1994 Dec; NS34(12):14. PubMed ID: 7856502
    [No Abstract]   [Full Text] [Related]  

  • 54. AIDS activists secure approval for human growth hormone (Serostim).
    Crit Path AIDS Proj; 1996; (No 31):34. PubMed ID: 11363832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Guidelines for recall of blood from AIDS donors? FDA says no.
    Med World News; 1983 Aug; 24(16):24. PubMed ID: 10261844
    [No Abstract]   [Full Text] [Related]  

  • 56. FDA Approves First Oral Treatment for Kidney Disease-Induced Anemia.
    Harris E
    JAMA; 2023 Mar; 329(9):704. PubMed ID: 36790833
    [No Abstract]   [Full Text] [Related]  

  • 57. FDA standardizes testing of AIDS workers' gloves.
    Public Health Rep; 1991; 106(2):217. PubMed ID: 1902317
    [No Abstract]   [Full Text] [Related]  

  • 58. FDA advises blood centers on phase-in of AIDS test.
    MLO Med Lab Obs; 1985 Apr; 17(4):21-3. PubMed ID: 10270782
    [No Abstract]   [Full Text] [Related]  

  • 59. FDA issues guidelines to protect transfusion recipients from AIDS.
    Hospitals; 1983 Jun; 57(12):59-60. PubMed ID: 6852801
    [No Abstract]   [Full Text] [Related]  

  • 60. Focus of new FDA division is AIDS, opportunistic infections.
    Clin Pharm; 1988 May; 7(5):337. PubMed ID: 3383541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.